Patients with follicular lymphoma (FL) experiencing early therapy failure (ETF) within 2 years
of frontline chemoimmunotherapy have poor overall survival (OS). We analyzed data from …

… transplantation (SCT) is widely used as salvage treatment for patients with relapsed follicular
lymphoma (… overall survival (OS) at 4 years post transplant was 59% and 84%, respectively, …

… There is also a paucity of standardized treatments for patients with POD24, but investigations
are ongoing testing novel targeted therapies and autologous stem cell transplantation …

… This study compared autologous hematopoietic stem cell transplantation (auto-HCT) with …
hematopoietic cell transplantation (allo-HCT) as the first transplantation approach for patients …

… Our practice is to consolidate with autologous transplant … Transplant Research and the
National LymphoCare Study, suggests that patients with early treatment failure undergoing early …

… no cytopenias, with no survival advantage for early treatment with either chemotherapy or
rituximab … Experimental therapies as well as stem cell transplantation (SCT) are considered for …

… therapy and autologous stem cell transplantation (ASCT) in transplant-eligible patients. We
… Follicular lymphoma (FL) is among the most common subtypes of non-Hodgkin lymphoma …

… transplant arm and 50 years for the chemotherapy arm. For this study, patients with a Follicular
Lymphoma … One trial ( 11 ) was stopped early because benefit in EFS favoring ASCT was …

… Autologous stem cell transplant (ASCT) has been shown to be an effective treatment for
follicular lymphoma (FL). We explored our experience in ASCT for FL among all patients treated …

… Less than 20% of patients with follicular lymphoma (FL) present with Ann Arbor Stage I or
II … therapy is considered the standard of care for early-stage disease based on single-institution …